Lv55
1490 积分 2026-03-16 加入
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC database
6天前
已完结
Structural Insights into Helix–Loop–Helix Peptides for “Ligand-Targeting” Intracellular Drug Delivery via VEGF Receptor-Mediated Endocytosis
11天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
23天前
已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
23天前
已完结
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
27天前
已完结
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
29天前
已完结
Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer
29天前
已完结
Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers
29天前
已完结
Linking tumour angiogenesis and tumour immunity
1个月前
已完结
The therapeutic window of antibody drug conjugates: A dogma in need of revision
1个月前
已完结
皖公网安备34019202002308
